Alaunos Therapeutics, Inc. Other Nonoperating Gains (Losses)
Alaunos Therapeutics, Inc. (TCRT) reported Other Nonoperating Gains (Losses) of -$7.41 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-10-22.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingGainsLosses · last filed 2013-10-22
- Alaunos Therapeutics, Inc. other nonoperating gains (losses) for the quarter ending 2013-09-30 was -$7.41M, a 287.76% decline year-over-year.
- Alaunos Therapeutics, Inc. other nonoperating gains (losses) for the quarter ending 2013-06-30 was -$403.00K.
- Alaunos Therapeutics, Inc. other nonoperating gains (losses) for the quarter ending 2013-03-31 was $10.79M.
- Alaunos Therapeutics, Inc. other nonoperating gains (losses) for the quarter ending 2012-12-31 was $8.57M, a 171.08% increase year-over-year.
- Alaunos Therapeutics, Inc. other nonoperating gains (losses) for fiscal 2012 was $6.05M, a 20.22% decline from fiscal 2011.
- Alaunos Therapeutics, Inc. other nonoperating gains (losses) for fiscal 2011 was $7.58M.
- Alaunos Therapeutics, Inc. other nonoperating gains (losses) for fiscal 2010 was -$8.89M, a 299.26% decline from fiscal 2009.
- Alaunos Therapeutics, Inc. other nonoperating gains (losses) for fiscal 2009 was $4.46M.
| Period end | Other Nonoperating Gains (Losses) 3 month | Other Nonoperating Gains (Losses) 6 month | Other Nonoperating Gains (Losses) 9 month | Other Nonoperating Gains (Losses) 12 month | Other Nonoperating Gains (Losses) 85 month | Other Nonoperating Gains (Losses) 94 month | Other Nonoperating Gains (Losses) 97 month | Other Nonoperating Gains (Losses) 100 month | Other Nonoperating Gains (Losses) 103 month | Other Nonoperating Gains (Losses) 106 month | Other Nonoperating Gains (Losses) 109 month | Other Nonoperating Gains (Losses) 112 month | Other Nonoperating Gains (Losses) 115 month | Other Nonoperating Gains (Losses) 118 month | Other Nonoperating Gains (Losses) 121 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | -$7.41M 10-Q · filed 2013-10-22 | -$7.81M derived: sum of 2 quarters · filed 2013-10-22 | $2.98M 10-Q · filed 2013-10-22 | $11.54M derived: sum of 4 quarters · filed 2013-10-22 | $13.75M 10-Q · filed 2013-10-22 | ||||||||||
| 2013-06-30 | -$403.00K 10-Q · filed 2013-08-08 | $10.38M 10-Q · filed 2013-08-08 | $18.95M derived: sum of 3 quarters · filed 2013-08-08 | $22.90M derived: sum of 4 quarters · filed 2013-10-22 | $21.16M 10-Q · filed 2013-08-08 | ||||||||||
| 2013-03-31 | $10.79M 10-Q · filed 2013-05-07 | $19.35M derived: sum of 2 quarters · filed 2013-05-07 | $23.30M derived: sum of 3 quarters · filed 2013-10-22 | $22.65M derived: sum of 4 quarters · filed 2013-10-22 | $21.56M 10-Q · filed 2013-05-07 | ||||||||||
| 2012-12-31 | $8.57M 10-K · filed 2013-03-18 | $12.51M derived: sum of 2 quarters · filed 2013-10-22 | $11.86M derived: sum of 3 quarters · filed 2013-10-22 | $6.05M 10-K · filed 2013-03-18 | $10.77M 10-K · filed 2013-03-18 | ||||||||||
| 2012-09-30 | $3.94M 10-Q · filed 2013-10-22 | $3.29M derived: sum of 2 quarters · filed 2013-10-22 | -$2.52M 10-Q · filed 2013-10-22 | $644.00K derived: sum of 4 quarters · filed 2013-10-22 | $2.21M 10-Q · filed 2012-11-08 | ||||||||||
| 2012-06-30 | -$650.00K 10-Q · filed 2013-08-08 | -$6.46M 10-Q · filed 2013-08-08 | -$3.30M derived: sum of 3 quarters · filed 2013-08-08 | $10.09M derived: sum of 4 quarters · filed 2013-08-08 | -$1.74M 10-Q/A · filed 2012-08-28 | ||||||||||
| 2012-03-31 | -$5.81M 10-Q · filed 2013-05-07 | -$2.65M derived: sum of 2 quarters · filed 2013-05-07 | $10.74M derived: sum of 3 quarters · filed 2013-05-07 | $12.85M derived: sum of 4 quarters · filed 2013-05-07 | -$1.09M 10-Q · filed 2012-05-03 | ||||||||||
| 2011-12-31 | $3.16M 10-K · filed 2013-03-18 | $16.55M derived: sum of 2 quarters · filed 2013-03-18 | $18.66M derived: sum of 3 quarters · filed 2013-03-18 | $7.58M 10-K · filed 2013-03-18 | $4.72M 10-K · filed 2012-02-29 | ||||||||||
| 2011-09-30 | $13.39M 10-K · filed 2013-03-18 | $15.50M derived: sum of 2 quarters · filed 2013-03-18 | $4.42M 10-Q · filed 2012-11-08 | -$1.80M derived: sum of 4 quarters · filed 2013-03-18 | $1.56M 10-Q · filed 2011-11-03 | ||||||||||
| 2011-06-30 | $2.12M 10-K · filed 2013-03-18 | -$8.96M 10-Q/A · filed 2012-08-28 | -$15.19M derived: sum of 3 quarters · filed 2013-03-18 | -$18.90M derived: sum of 4 quarters · filed 2013-03-18 | -$11.83M 10-Q/A · filed 2011-08-09 | ||||||||||
| 2011-03-31 | -$11.08M 10-K · filed 2013-03-18 | -$17.31M derived: sum of 2 quarters · filed 2013-03-18 | -$21.02M derived: sum of 3 quarters · filed 2013-03-18 | -$6.88M derived: sum of 4 quarters · filed 2013-03-18 | |||||||||||
| 2010-12-31 | -$6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$9.94M derived: sum of 2 quarters · filed 2013-03-18 | $4.20M derived: sum of 3 quarters · filed 2013-03-18 | -$8.89M 10-K · filed 2013-03-18 | |||||||||||
| 2010-09-30 | -$3.71M 10-Q · filed 2011-11-03 | $10.43M derived: sum of 2 quarters · filed 2011-11-03 | -$2.66M 10-Q · filed 2011-11-03 | $3.36M 10-Q · filed 2011-08-01 | |||||||||||
| 2010-06-30 | $14.14M 10-Q/A · filed 2011-08-09 | $1.05M 10-Q/A · filed 2011-08-09 | |||||||||||||
| 2009-12-31 | $4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $4.68M derived: sum of 2 quarters · filed 2012-02-29 | $4.46M 10-K · filed 2012-02-29 | ||||||||||||
| 2009-09-30 | -$304.00K 10-Q · filed 2011-08-01 | -$520.00K 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |